Major event shines spotlight on neurological disorders

Image of a cortical neuroneWorld experts in neurological disorders will meet at the University this week to discuss how new research can help shape future treatments for people living with conditions such as Motor Neurone Disease, Alzheimer’s and Parkinson’s.

Coinciding with Motor Neurone Disease Awareness Month, taking place throughout June, this week’s conference will look at disorders of the brain, spinal cord and nervous system to discuss how they advance and develop in the body.

Such disorders are a leading cause of disability, affecting an estimated 1 billion people worldwide. In the UK alone, approximately 50 people are diagnosed every hour and neurological conditions, which include depression, affect around 10 million people.

For people living with conditions such as Motor Neurone Disease, Alzheimer’s and Parkinson’s, understanding what goes wrong in part of the nervous system will lead to better treatments. The focus of next week’s conference is on understanding these important mechanisms.

Organised in partnership with the European Society for Neurochemistry (ESN) and Biochemical Society, the event takes place on campus from Monday 24 – Wednesday 26 June. This week's event will bring together leading academic and industrial scientists from 29 countries around the world and marks the return of annual event to Bath; the very first Conference was held here nearly 40 years ago in 1976.

Commenting on the advancements in research seen over this period, Chair of the Organising Committee Professor Marcus Rattray said: “There have been amazing advances in understanding the causes of these important diseases with a realistic prospect of discovering new treatments in the next decade.”

Dr Rob Williams, from the our Department of Biology & Biochemistry, added: “Bath has historically led research in this area and this continues today. We’re proud to bring back such a major event and to showcase some of the pioneering neuroscience research taking place here at the university.”Astrocyte

Among other leading figures from the world of neuroscience, delegates attending will hear from Dr Michael Ehlers, Chief Scientific Officer at Pfizer Neuroscience US; Dr Daniel Geschwind from the University of California’s Neurology and Psychiatry Department; and Professor David Attwell from University College London (UCL).

To follow tweets from the Conference search #jointesnbs2013. These will also be highlighted via @uniofbath.

Related links

Conference Information – Fifth Conference on Advances in Molecular Mechanisms Underlying Neurological Disorders, ESN Bath 2013.

‘What is a Neurological Disease’ – Movement for Hope

Motor Neurone Awareness Month – MND Association

Bookmark with:

What is this?

We are one of the UK's leading universities with an international reputation for quality research and teaching. Our Mission is to deliver world class research and teaching, educating our graduates to become future leaders and innovators, and benefiting the wider population through our research, enterprise and influence. Our courses are innovative and interdisciplinary and we have an outstanding record of graduate employment.